Breast cancer screening pamphlets mislead women

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Gigerenzer, Gerd ^a  

^a MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; DECISION MAKING; EARLY DIAGNOSIS; FEMALE; FRANCE; GERMANY; HUMAN; MAMMOGRAPHY; NETHERLANDS; PATERNALISM; PRIORITY JOURNAL; PUBLICATION; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; SURVIVAL RATE;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INFORMED CONSENT; PAMPHLETS; PATIENT EDUCATION AS TOPIC; PATIENT RIGHTS; RISK FACTORS; SURVIVAL RATE;

EID: 84899534915     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2636     Document Type: Short Survey

References (5)

1. Gigerenzer G, Mata J, Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst 2009;101:1216-20.
2. Schwartz LM, Woloshin S. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med 2009;150:516-27.
3. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6:CD001877.
4. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA 2000;283:2975-8.
5. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ 2014;348:g366.